NCT00202709

Brief Summary

The purpose of this study is to find out if Thought Field Therapy has effect on certain anxiety disorders; agoraphobia, social phobia, and post traumatic stress disorder (PTSD).

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
52

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started May 2002

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

May 1, 2002

Completed
1.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 1, 2003

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

August 1, 2003

Completed
2.1 years until next milestone

First Submitted

Initial submission to the registry

September 12, 2005

Completed
8 days until next milestone

First Posted

Study publicly available on registry

September 20, 2005

Completed
Last Updated

July 28, 2011

Status Verified

September 1, 2005

Enrollment Period

1.3 years

First QC Date

September 12, 2005

Last Update Submit

July 27, 2011

Conditions

Keywords

Anxiety disorderThought Field TherapyPsychotherapyAgoraphobiaSocial PhobiaPost Traumatic Stress Disorder

Outcome Measures

Primary Outcomes (1)

  • Global symptom index (gsi) on the Symptom checklist 90 revised (SCL-90-R)

    Before treatment/wait list period, just after treatment, 3 months and 12 months after treatment. Group A also 6 months after treatment.

Secondary Outcomes (5)

  • Davidson Trauma Scale

    Before treatment/wait list period, just after treatment, 3 months and 12 months after treatment. Group A also 6 months after treatment.

  • Liebowitz Social Anxiety Scale

    Before treatment/wait list period, just after treatment, 3 months and 12 months after treatment. Group A also 6 months after treatment.

  • Hospital Anxiety and Depression Scale (HADS)

    Before treatment/wait list period, just after treatment, 3 months and 12 months after treatment. Group A also 6 months after treatment.

  • Fear Questionnaire (FQ)

    Before treatment/wait list period, just after treatment, 3 months and 12 months after treatment. Group A also 6 months after treatment.

  • Sheehan Disability Scale

    Before treatment/wait list period, just after treatment, 3 months and 12 months after treatment. Group A also 6 months after treatment.

Study Arms (2)

Thought Field Therapy (TFT)

EXPERIMENTAL

Treatment with TFT, first one hour, then 1/2 hour.

Behavioral: Thought Field Therapy (TFT)

Wait list control

NO INTERVENTION

Interventions

Treatment with TFT twice in one week

Also known as: Wait list control
Thought Field Therapy (TFT)

Eligibility Criteria

Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

  • One or more of the study diagnoses agoraphobia, social phobia and/or PTSD

You may not qualify if:

  • Ongoing psychosis
  • Ongoing serious drug problems

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Sorlandet Hospital

Arendal, 4809, Norway

Location

Related Publications (1)

  • Irgens A, Dammen T, Nysaeter TE, Hoffart A. Thought Field Therapy (TFT) as a treatment for anxiety symptoms: a randomized controlled trial. Explore (NY). 2012 Nov-Dec;8(6):331-8. doi: 10.1016/j.explore.2012.08.002.

MeSH Terms

Conditions

AgoraphobiaPhobia, SocialStress Disorders, Post-TraumaticAnxiety Disorders

Condition Hierarchy (Ancestors)

Phobic DisordersMental DisordersStress Disorders, TraumaticTrauma and Stressor Related Disorders

Study Officials

  • Audun C Irgens, MD

    Sorlandet Hospital HF

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER GOV

Study Record Dates

First Submitted

September 12, 2005

First Posted

September 20, 2005

Study Start

May 1, 2002

Primary Completion

August 1, 2003

Study Completion

August 1, 2003

Last Updated

July 28, 2011

Record last verified: 2005-09

Locations